Acylcarnitines: Analysis in Plasma and Whole Blood Using Tandem Mass Spectrometry

Methods in Molecular Biology

Volumn 708, Issue , 2011, Pages 55-72

  Millington, David S ^a   Stevens, Robert D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acylcarnitines; fatty acid oxidation; inherited metabolic disease; metabolomics; tandem mass spectrometry

Indexed keywords

ACYLCARNITINE; CARNITINE; DRUG DERIVATIVE; ESTER;

ANALYSIS; ARTICLE; BLOOD; BLOOD ANALYSIS; BLOOD SAMPLING; CHEMISTRY; FILTRATION; HUMAN; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; PAPER; PLASMA; REPRODUCIBILITY; STANDARD; TANDEM MASS SPECTROMETRY; TIME;

ANALYTIC SAMPLE PREPARATION METHODS; BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; CARNITINE; ESTERS; FILTRATION; HUMANS; PAPER; PLASMA; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 79953765653     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61737-985-7_3     Document Type: Chapter

References (15)

1. Kler, R. S., Jackson, S., Bartlett, K., Bindoff, L. A., Eaton, S., Pourfarzam, M., Frerman, F. E., Goodman, S. I., Watmough, N. J., Turnbull, D. M. (1991) Quantitation of acyl-coA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation. J Biol Chem 266, 22932–22939.
2. Millington, D. S. (2003) Tandem mass spectrometry in clinical diagnosis, in (Blau, N., Duran, M., Blaskovics, M. E., Gibson, M., eds.), Physician’s Guide to the Laboratory Diagnosis of Metabolic Diseases, 2nd edn, pp. E57–75. Springer, Berlin.
3. Millington, D. S., Chace, D. H. (1992) Carnitine and acylcarnitines in metabolic disease diagnosis and management, in (Deside-rio, D. M., ed.), Mass Spectrometry: Clinical and Biomedical Applications, Vol. 1, pp. 199–219. Plenum Press, New York, NY.
4. Rinaldo, P., Cowan, T. M., Matern, D. (2008) Acylcarnitine profile analysis. Genet Med 10, 151–156.
5. Sweetman, L., Millington, D. S., Therrell, B. L., Hannon, W. H., Popovich, B., Watson, M. S., Mann, M. Y., Loyd-Puryear, M. A. (2006) Naming and counting disorders (con-ditions) included in newborn screening panels. Pediatrics 117, S308–S314.
6. Chace, D. H., Kalas, T. A., Naylor, E. W. (2003) Use of tandem mass spectrometry for multianalyte screening of dried blood spot specimens from newborns. Clin Chem 49, 1797–1817.
7. Frazier, D. M., Millington, D. S., McCandless, S. E., Koeberl, D. D., Weavil, S. D., Chaing, S. H., Muenzer, J. (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997– 2005. J Inherit Metab Dis 29, 76–85.
8. Ventura, F. V., Costa, C. G., Struys, E. A., Ruiter, J., Allers, P., Ijlst, L., Tavares de Almeida, I., Duran, M., Jakobs, C., Wanders, R. J. (1999) Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta 281, 1–17.
9. Roe, C. R., Roe, D. S. (2000) Detection of gene defects in branched-chain amino acid metabolism by tandem mass spectrometry of carnitine esters produced by cultured fibroblasts. Methods Enzymol 324, 424–431.
10. Kao, H.-J., Cheng, C.-F., Chen, Y.-H., Hung, S.-I., Huang, C.-C., Millington, D., Kikuchi, T., Wu, J.-Y., Chen, Y.-T. (2006) ENU mutagenesis identifies mice with cardiac fibrosis and hepatic steatosis caused by a mutation in the mitochondrial trifunctional protein beta-subunit. Hum Mol Genet 15, 3569–3577.
11. Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., Rochon, J., Gallup, D., Ilkayeva, O., Wenner, B. R., Yancey, W. S. Jr., Eisenson, H., Musante, G., Surwit, R., Millington, D. S., Butler, M. D., Svetkey, L. P. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9, 311–326.
12. Stevens, R. D., Hillman, S., Worthy, L. S., Sanders, D., Millington, D. S. (2000) Assay for free and total carnitine in human plasma using tandem mass spectrometry. Clin Chem 46, 727–729.
13. Minkler, P. E., Stoll, M. S., Ingalls, S. T., Yang, S., Kerner, J., Hoppel, C. L. (2008) Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization–mass spectrometry. Clin Chem 54, 1451–1462.
14. Rizzo, C., Boenzi, S., Wanders, R. J., Duran, M., Caruso, U., Dionisi-Vici, C. (2003) Characteristic acylcarnitine profiles in inherited defects of peroxisome biogenesis: a novel tool for screening diagnosis using tandem mass spectrometry. Pediatr Res 53, 1013–1018.
15. Gallaher, R. C., Cowan, T. M., Goodman, S. I., Enns, G. M. (2005) Glutaryl-CoA dehydrogenase deficiency and newborn screening: retrospective analysis of a low excretor provides further evidence that some cases may be missed. Mol Genet Metab 86, 417–420.